Brainstorm Cell Therapeutics(BCLI) - 2023 Q4 - Annual Results
Brainstorm Cell Therapeutics(BCLI)2024-04-01 12:15Exhibit 99.1 BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update Conference call planned for early April 2024 to provide update on NurOwn program NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the full year ended December 31, 2023 and provided a corporate update. "Brainstorm's priority for 2024 i ...